Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,445.65
1,002.47
6,422.45
4,501.40
4,751.25
362.72
300.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,445.65
1,002.47
6,422.45
4,501.40
4,751.25
362.72
300.03
Raw Material Cost
454.10
381.82
2,729.62
1,323.88
992.86
144.78
142.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
95.41
80.04
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
19.09
5.53
3.03
1.83
0.99
0.62
0.09
Selling and Distribution Expenses
682.82
482.22
939.36
472.71
604.41
148.43
121.83
Other Expenses
21.00
16.15
31.22
17.87
7.77
-6.09
-4.83
Total Expenditure (Excl Depreciation)
1,366.02
1,031.10
3,984.22
1,977.09
1,675.97
328.32
296.09
Operating Profit (PBDIT) excl Other Income
79.6
-28.599999999999998
2438.2
2524.3
3075.2999999999997
34.4
3.9000000000000004
Other Income
174.59
394.35
70.43
13.60
-4.54
10.36
6.86
Operating Profit (PBDIT)
470.15
513.09
2,353.78
2,596.86
3,099.41
67.29
32.46
Interest
19.09
5.53
3.03
1.83
0.99
0.62
0.09
Exceptional Items
12.01
61.84
82.60
86.13
0.42
1.33
0.00
Gross Profit (PBDT)
991.55
620.66
3,692.83
3,177.53
3,758.39
217.94
157.57
Depreciation
170.57
136.77
97.43
58.95
28.67
22.54
21.68
Profit Before Tax
292.50
432.64
2,335.92
2,622.21
3,070.16
45.46
10.69
Tax
34.34
62.31
379.21
373.68
453.56
5.98
3.93
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
275.60
363.72
1,936.80
2,242.70
2,616.60
39.48
6.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
275.60
363.72
1,936.80
2,242.70
2,616.60
39.48
6.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-49.32
-15.55
-0.09
-0.17
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
226.27
348.17
1,936.71
2,242.52
2,616.60
39.48
6.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,243.23
7,201.27
7,500.62
6,368.91
4,745.43
557.48
396.29
Earnings per share (EPS)
0.48
0.64
3.35
3.79
4.42
0.07
0.01
Diluted Earnings per share
0.48
0.64
3.35
3.79
4.42
0.07
0.01
Operating Profit Margin (Excl OI)
8.65%
-1.8%
34.04%
56.08%
64.73%
9.48%
1.31%
Gross Profit Margin
32.03%
56.8%
37.89%
59.56%
65.22%
18.75%
10.79%
PAT Margin
19.06%
36.28%
30.16%
49.82%
55.07%
10.88%
2.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 44.20% vs -84.39% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -35.01% vs -82.02% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 149.03% vs -94.80% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 247.27% vs 83.33% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Sansure Biotech, Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,445.65
0
1,445.65
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,445.65
0
1,445.65
Raw Material Cost
454.10
0
454.10
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
19.09
0
19.09
Selling and Distribution Expenses
682.82
0
682.82
Other Expenses
21.00
0.00
21.00
Total Expenditure (Excl Depreciation)
1,366.02
0
1,366.02
Operating Profit (PBDIT) excl Other Income
79.63
0.00
79.63
Other Income
174.59
0
174.59
Operating Profit (PBDIT)
470.15
0
470.15
Interest
19.09
0
19.09
Exceptional Items
12.01
0
12.01
Gross Profit (PBDT)
991.55
0
991.55
Depreciation
170.57
0
170.57
Profit Before Tax
292.50
0
292.50
Tax
34.34
0
34.34
Provisions and contingencies
0
0
0.00
Profit After Tax
275.60
0
275.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
275.60
0
275.60
Share in Profit of Associates
0
0
0.00
Minority Interest
-49.32
0
-49.32
Other related items
0.00
0.00
0.00
Consolidated Net Profit
226.27
0
226.27
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,243.23
0
7,243.23
Earnings per share (EPS)
0.48
0
0.48
Diluted Earnings per share
0.48
0
0.48
Operating Profit Margin (Excl OI)
8.65%
0%
0.00
8.65%
Gross Profit Margin
32.03%
0%
0.00
32.03%
PAT Margin
19.06%
0%
0.00
19.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 144.56 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 44.20% vs -84.39% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 22.63 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -35.01% vs -82.02% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.56 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 149.03% vs -94.80% in Dec 2023
Annual - Interest
Interest 1.91 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 247.27% vs 83.33% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.65%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






